FDA Approved: TOBRADEX ST — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved a supplemental application for TOBRADEX ST (tobramycin/dexamethasone) from Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis
• Eye Inflammation
• Ocular Infection

Drugs mentioned

• TOBRADEX ST (TOBRAMYCIN / DEXAMETHASONE)

Snippet

SUPPL AP for TOBRADEX ST (TOBRAMYCIN / DEXAMETHASONE)